FR2336939A1 - Fraction inductrice d'une resistance aux infections bacteriennes, extractible de bacteries notamment gram negatif ou de leurs parois, procede d'obtention d'une telle fraction et medicaments la contenant - Google Patents

Fraction inductrice d'une resistance aux infections bacteriennes, extractible de bacteries notamment gram negatif ou de leurs parois, procede d'obtention d'une telle fraction et medicaments la contenant

Info

Publication number
FR2336939A1
FR2336939A1 FR7540041A FR7540041A FR2336939A1 FR 2336939 A1 FR2336939 A1 FR 2336939A1 FR 7540041 A FR7540041 A FR 7540041A FR 7540041 A FR7540041 A FR 7540041A FR 2336939 A1 FR2336939 A1 FR 2336939A1
Authority
FR
France
Prior art keywords
atoxic
esp
biologically active
bacterial infection
crude extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7540041A
Other languages
English (en)
French (fr)
Other versions
FR2336939B1 (cg-RX-API-DMAC10.html
Inventor
Jean Choay
Mireille Sakouhi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Choay SA
Original Assignee
Choay SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choay SA filed Critical Choay SA
Priority to FR7540041A priority Critical patent/FR2336939A1/fr
Priority to US05/752,993 priority patent/US4148877A/en
Priority to JP15765376A priority patent/JPS5282713A/ja
Priority to DE19762659431 priority patent/DE2659431A1/de
Publication of FR2336939A1 publication Critical patent/FR2336939A1/fr
Application granted granted Critical
Publication of FR2336939B1 publication Critical patent/FR2336939B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/22—Klebsiella
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
FR7540041A 1975-12-29 1975-12-29 Fraction inductrice d'une resistance aux infections bacteriennes, extractible de bacteries notamment gram negatif ou de leurs parois, procede d'obtention d'une telle fraction et medicaments la contenant Granted FR2336939A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR7540041A FR2336939A1 (fr) 1975-12-29 1975-12-29 Fraction inductrice d'une resistance aux infections bacteriennes, extractible de bacteries notamment gram negatif ou de leurs parois, procede d'obtention d'une telle fraction et medicaments la contenant
US05/752,993 US4148877A (en) 1975-12-29 1976-12-21 Fraction capable of inducing in vivo a resistance to bacterial infections, process for obtaining said fraction from bacteria and drugs containing said fraction
JP15765376A JPS5282713A (en) 1975-12-29 1976-12-28 Preparation of bioactive fraction and ittcontaining medicine
DE19762659431 DE2659431A1 (de) 1975-12-29 1976-12-29 Verfahren zur gewinnung einer atoxischen, biologisch aktiven fraktion, die dabei erhaltene fraktion und sie enthaltende arzneimittel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7540041A FR2336939A1 (fr) 1975-12-29 1975-12-29 Fraction inductrice d'une resistance aux infections bacteriennes, extractible de bacteries notamment gram negatif ou de leurs parois, procede d'obtention d'une telle fraction et medicaments la contenant

Publications (2)

Publication Number Publication Date
FR2336939A1 true FR2336939A1 (fr) 1977-07-29
FR2336939B1 FR2336939B1 (cg-RX-API-DMAC10.html) 1978-08-11

Family

ID=9164277

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7540041A Granted FR2336939A1 (fr) 1975-12-29 1975-12-29 Fraction inductrice d'une resistance aux infections bacteriennes, extractible de bacteries notamment gram negatif ou de leurs parois, procede d'obtention d'une telle fraction et medicaments la contenant

Country Status (1)

Country Link
FR (1) FR2336939A1 (cg-RX-API-DMAC10.html)

Also Published As

Publication number Publication date
FR2336939B1 (cg-RX-API-DMAC10.html) 1978-08-11

Similar Documents

Publication Publication Date Title
ATE73347T1 (de) Antivirales immunotherapeutisches mittel und dessen herstellung.
MY103388A (en) Azithromycin and derivatives as antiprotozoal agents
AU553185B2 (en) Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them
PT1042340E (pt) Oxima de 6-o-alquil-eritromicina b
YU174491A (sh) Vakcine
DE3066115D1 (en) Immuno-stimulating preparations based on ribosomal rna of klebsiella pneumoniae and process for the preparation of these rna
RU93004600A (ru) Применение mycobacterium vaccae, способ лечения, продукт m vaccae, иммунотерапевтический агент
PT600396E (pt) Vacinas contra protozoarios intestinais
FR2351664A2 (fr) Fraction inductrice d'une resistance aux infections bacteriennes, extractible de bacteries notamment gram negatif ou de leurs parois, procede d'obtention d'une telle fraction et medicaments la contenant
FR2336939A1 (fr) Fraction inductrice d'une resistance aux infections bacteriennes, extractible de bacteries notamment gram negatif ou de leurs parois, procede d'obtention d'une telle fraction et medicaments la contenant
WO1990013281A3 (en) Method of suppressing hiv infection
WO1999051256A3 (en) Use of l-glu-l-trp in the treatment of hiv infection
DE10399019I1 (de) Gefluegelkrankheit verursachende neue Bakterie unddaraus stammender Impfstoff
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
EP0057349A3 (en) Peptide antibiotic, component b, process for its preparation and its use in medicines
EP0090660A3 (en) Neisseria gonorrhoeae vaccine
MX9200755A (es) Tratamiento de carcinoma pulmonar de celulas no pequeñas.
IT8121484A0 (it) Estratto da piante del genere epimedium, procedimento per lapreparazione di detto estratto, agente immunostimolante che comprende detto estratto come componente efficace e immunoterapia mediante l'impiego di detto estratto.
EP0250115A3 (en) 2,5-pyrrolidine dione derivatives obtained from bacteriae, and their use as bactericides
ES353533A1 (es) Procedimiento para la preparacion de una vacuna antitetani-ca.
CA2122604A1 (en) Uses of aloe products, e.g. acemannan, in the treatment of diseases requiring intervention of the immune system for cure
WO1988007367A3 (en) Melatonin-derivatives for psychogenic stress and acute anxiety, and immuno-stimulant drugs
DK621688A (da) Ethylerede avermectiner og praeparater indeholdende disse til behandling og forhindring af parasitinfektioner hos mennesker og dyr
FR2307542A1 (fr) Nouvelle preparation immunostimulante
DE384635C (de) Verfahren zur Herstellung von Impfstoffen aus menschlichen Tuberkelbazillen oder Rindertuberkelbazillen zur Schutzimpfung gegen Tuberkulose

Legal Events

Date Code Title Description
ST Notification of lapse